← Leaderboards
Stephen H. Embury
University Of California San Francisco
$4,037,116
Attributed
$4,037,116
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2014–17$2M$1.5M$1M$500K$0
'14
'15
'16
'17
Funding mix
By agency
NIH$4,037,116 · 5
By mechanism
R44$1,992,324 · 1
R01$1,250,190 · 1
R43$561,735 · 2
P60$232,867 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Teresa L. Wright$3,215,991
- Henry R Bourne$4,905,656
- William J Bodell$1,842,491
Others in their field
Top investigators on “Sickle Cell Anemia”
- Russell E Ware · Duke University$48,435,687
- Michael Rutledge Debaun · Vanderbilt University Medical Center$38,268,866
- Martin H. Steinberg · Boston Medical Center$25,628,557
- Michael L. Terrin · Clinical Trials And Surveys Corporation$23,855,067
- Barbara L Kroner · Research Triangle Institute$21,141,016
- Garret A Fitzgerald · University Of Pennsylvania$20,602,198
Research focus
Sickle Cell AnemiaCell AdhesionCell Adhesion MoleculesBlood Vessel OcclusionClinical ResearchVascular EndotheliumErythrocytesIntravital MicroscopyIn VitroAcute PainEventClinical TrialsBaseAdhesionsLegal PatentHemoglobinAcuteClinical DataInheritedBlood FlowBlood VesselsDrug KineticsBiological AvailabilityDose
Grant awards (13)
Improved Oral P-selectin Blocker for Prophylactic Sickle Cell Disease Therapy$324,169
R44 · FY2017 · HL · contact PI
Improved Oral P-selectin Blocker for Prophylactic Sickle Cell Disease Therapy$1,668,155
R44 · FY2016 · HL · contact PI
Reliable Assays for Pentosan Polysulfate Sodium$109,280
R43 · FY2015 · HL · contact PI
Reliable Assays for Pentosan Polysulfate Sodium$226,422
R43 · FY2014 · HL · contact PI
Improved Oral P-selectin Blocker for Prophylactic Sickle Cell Disease Therapy$226,033
R43 · FY2014 · HL · contact PI
ACTIVATED ENDOTHELIAL ADHESIVITY IN SC VASOOCCLUSION$319,663
R01 · FY2003 · HL
ACTIVATED ENDOTHELIAL ADHESIVITY IN SC VASOOCCLUSION$310,352
R01 · FY2002 · HL
ENDOTHELIAL CELL REACTIVITY IN SICKLE CELL VASOOCCLUSION$0
P60 · FY2002 · HL
ENDOTHELIAL CELL REACTIVITY IN SICKLE CELL VASOOCCLUSION$0
P60 · FY2002 · HL
ACTIVATED ENDOTHELIAL ADHESIVITY IN SC VASOOCCLUSION$301,149
R01 · FY2001 · HL
ENDOTHELIAL CELL REACTIVITY IN SICKLE CELL VASOOCCLUSION$0
P60 · FY2001 · HL
ACTIVATED ENDOTHELIAL ADHESIVITY IN SC VASOOCCLUSION$319,026
R01 · FY2000 · HL
ENDOTHELIAL CELL REACTIVITY IN SICKLE CELL VASOOCCLUSION$232,867
P60 · FY2000 · HL